iTIND Prostate Treatment Melbourne
iTIND is an innovative, minimally invasive treatment for benign prostatic hyperplasia (BPH) that uses a temporary implant to reshape the prostate and relieve urinary obstruction. Unlike other treatments, the device is removed after 5-7 days, leaving no permanent implant while providing lasting symptom relief.
Written and clinically reviewed by Dr Brendan Dias
Consultant Urologist & Robotic Surgeon · MBBS, MS (General Surgery), DrNB (Urology), IntFRCS (England), FUSANZ, FRACS (Urology)
Last clinically reviewed: 26 August 2026
Benefits
- No permanent implant left in the body
- Preserves sexual function including ejaculation
- Drug-free solution for BPH symptoms
- Quick procedure with no general anaesthesia required
- No cutting, burning, or removal of tissue
- Rapid recovery with minimal downtime
- Does not preclude future treatment options
- Sustained symptom improvement
The Procedure
The iTIND procedure involves two brief office visits. During the first visit, under local anaesthesia, a small device made of nitinol (a shape-memory alloy) is placed in the prostatic urethra through a cystoscope. Over the next 5-7 days, the device gently expands and reshapes the obstructing prostate tissue, creating channels that will remain open after the device is removed. During the second visit, the device is removed in a simple office procedure taking just minutes. The reshaped prostate tissue maintains its new configuration, allowing improved urine flow.
Who Is a Candidate?
iTIND is suitable for men with moderate BPH symptoms who want to avoid permanent implants or tissue removal. It is appropriate for prostates between 25 and 75 grams. iTIND is particularly attractive for younger men concerned about sexual function preservation, those who prefer the least invasive approach, and men who want to avoid the side effects associated with BPH medications. Dr Dias will evaluate your symptoms and prostate anatomy to determine if iTIND is a suitable option.
Recovery
After device placement, patients typically experience some urinary urgency and frequency while the device is in place. A temporary catheter may be used for the first few days. Once the device is removed at 5-7 days, these symptoms quickly improve. Most patients can return to normal activities within 1-2 days after device removal. Symptom improvement is typically noticeable within the first few weeks and continues to improve over 3 months.
Risks & Considerations
iTIND has a favourable safety profile. During the 5-7 days while the device is in place, patients commonly experience urgency, frequency, and some discomfort—these resolve once the device is removed. Urinary tract infection can occur but is uncommon with appropriate prophylaxis. There is no risk of erectile dysfunction or ejaculatory problems. As with any BPH procedure, some patients may require additional treatment in the future if symptoms are not adequately controlled or recur.